Design and application of an in vivo reporter assay for phenylalanine ammonia-lyase (Q45051847)

8 December 2017

title

Design and application of an in vivo reporter assay for phenylalanine ammonia-lyase (English)

1 reference

8 December 2017

Siyuan Wang

1

1 reference

8 December 2017

Shuwei Zhang

2

1 reference

8 December 2017

Tong Zhou

3

1 reference

8 December 2017

Jia Zeng

4

1 reference

8 December 2017

Jixun Zhan

5

1 reference

8 December 2017

language of work or name

English

0 references

publication date

2 August 2013

1 reference

Applied Microbiology and Biotechnology

8 December 2017

published in

1 reference

8 December 2017

volume

97

1 reference

8 December 2017

issue

17

1 reference

8 December 2017

page(s)

7877-7885

1 reference

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Curcumin: the Indian solid gold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Crystal structure of phenylalanine ammonia lyase: multiple helix dipoles implicated in catalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Curcumin as "Curecumin": from kitchen to clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Physiology and Molecular Biology of Phenylpropanoid Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

REVIEW: Curcumin and Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Curcumin: from ancient medicine to current clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Phenylalanine ammonia-lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Precursor-directed biosynthesis of curcumin analogs in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Curcuminoid biosynthesis by two type III polyketide synthases in the herb Curcuma longa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

In vitro synthesis of curcuminoids by type III polyketide synthase from Oryza sativa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Production of curcuminoids by Escherichia coli carrying an artificial biosynthesis pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Comparison of real-time PCR methods for detection of Salmonella enterica and Escherichia coli O157:H7, and introduction of a general internal amplification control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Immunomodulatory effects of curcumin in allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

A modern view of phenylalanine ammonia lyase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Curcumin attenuates ovalbumin-induced airway inflammation by regulating nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

A novel reporter system for bacterial and mammalian cells based on the non-ribosomal peptide indigoidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Structural basis for the entrance into the phenylpropanoid metabolism catalyzed by phenylalanine ammonia-lyase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Phenylpropanoid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Biochemical characterization of a prokaryotic phenylalanine ammonia lyase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

An indigoidine biosynthetic gene cluster from Streptomyces chromofuscus ATCC 49982 contains an unusual IndB homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Type III polyketide synthases in natural product biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

Stress-Induced Phenylpropanoid Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00253-013-5122-4

10.1007/S00253-013-5122-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

8 December 2017

1042899702

0 references

1 reference